Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Cancer Discovery|August 31, 2023
Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic ImplicationsBritta Weigelt, Antonio Marra, Pier Selenica, et al.
Breast Cancer Research and Treatment|October 30, 2024
Molecular tumor board in patients with metastatic breast cancerLuca Boscolo Bielo, Elena Guerini Rocco, Edoardo Crimini, et al.
The Oncologist|August 7, 2023
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted AgentsEleonora Nicolò, Paolo Tarantino, Oriana D'Ecclesiis, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
Cancers|January 8, 2025
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I UnitAngela Esposito, Edoardo Crimini, Carmen Criscitiello, et al.
NPJ Breast Cancer|July 10, 2025
Genomic landscape of breast cancer in elderly patientsPier Selenica, Higinio Dopeso, Matteo Repetto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2023
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic CharacterizationFatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, et al.
Gynecologic Oncology|May 28, 2023
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinomaEric Rios-Doria, Amir Momeni-Boroujeni, Claire F Friedman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2022
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung CancersNoura J Choudhury, Antonio Marra, Jane S Y Sui, et al.
Journal of the National Cancer Institute|January 25, 2022
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic ImplicationsTony El Jabbour, Maksym Misyura, Darren Cowzer, et al.
Pageof 11